Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yee-Ying Lee, Teck-Kim Tang, Eng-Seng Chan, Eng-Tong Phuah, Oi-Ming Lai, Chin-Ping Tan, Yong Wang, Nur Azwani Ab Karim, Noorlida Habi Mat Dian & Joo Shun Tan. (2022) Medium chain triglyceride and medium-and long chain triglyceride: metabolism, production, health impacts and its applications – a review. Critical Reviews in Food Science and Nutrition 62:15, pages 4169-4185.
Read now
Read now
Articles from other publishers (56)
Yunlong Xu, Fuxiang ZhengQi Zhong & Yingjie Zhu. (2023) Ketogenic Diet as a Promising Non-Drug Intervention for Alzheimer’s Disease: Mechanisms and Clinical Implications. Journal of Alzheimer's Disease 92:4, pages 1173-1198.
Crossref
Crossref
Ksenia Shcherbakova, Alexander Schwarz, Irina Ivleva, Veronika Nikitina, Darya Krytskaya, Sergey Apryatin, Marina Karpenko & Alexander Trofimov. (2023) Short- and long-term cognitive and metabolic effects of medium-chain triglyceride supplementation in rats. Heliyon 9:2, pages e13446.
Crossref
Crossref
Xianqian Li, Min Ji, Hongmei Zhang, Zunjian Liu, Yujing Chai, Qi Cheng, Yue Yang, Dennis Cordato & Jianqun Gao. (2022) Non-drug Therapies for Alzheimer’s Disease: A Review. Neurology and Therapy 12:1, pages 39-72.
Crossref
Crossref
Carolina B Castro, Cintia B Dias, Heidi Hillebrandt, Hamid R Sohrabi, Pratishtha Chatterjee, Tejal M Shah, Stephanie J Fuller, Manohar L Garg & Ralph N Martins. (2023) Medium-chain fatty acids for the prevention or treatment of Alzheimer’s disease: a systematic review and meta-analysis. Nutrition Reviews.
Crossref
Crossref
Yinuo Wang, Junyao Zhang, Yingying Zhang & Junyan Yao. (2023) Bibliometric analysis of global research profile on ketogenic diet therapies in neurological diseases: Beneficial diet therapies deserve more attention. Frontiers in Endocrinology 13.
Crossref
Crossref
Étienne Myette-Côté, Adrian Soto-Mota & Stephen C. Cunnane. (2021) Ketones: potential to achieve brain energy rescue and sustain cognitive health during ageing. British Journal of Nutrition 128:3, pages 407-423.
Crossref
Crossref
Ksenia Shcherbakova, Alexander Schwarz, Sergey Apryatin, Marina Karpenko & Alexander Trofimov. (2022) Supplementation of Regular Diet With Medium-Chain Triglycerides for Procognitive Effects: A Narrative Review. Frontiers in Nutrition 9.
Crossref
Crossref
Raysa El-Zein, J. L. Murphy, S. Shanker & P. W. Thomas. (2022) The Effectiveness of Dietary-Induced Ketogenesis on Cognition in Older Adults: A Scoping Review of the Literature. SN Comprehensive Clinical Medicine 4:1.
Crossref
Crossref
Abigail Espina, Eduardo Mendoza & Angelyn Lao. (2022) Modelling the Effects of Medium-Chain Triglycerides on Cerebral Ketone Body Metabolism. Frontiers in Systems Biology 2.
Crossref
Crossref
Shinji Watanabe & Shougo Tsujino. (2022) Applications of Medium-Chain Triglycerides in Foods. Frontiers in Nutrition 9.
Crossref
Crossref
H. Şimşek & A. Uçar. (2022) Is Ketogenic Diet Therapy a Remedy for Alzheimer’s Disease or Mild Cognitive Impairments?: A Narrative Review of Randomized Controlled Trials. Advances in Gerontology 12:2, pages 200-208.
Crossref
Crossref
Jennifer To, Zi Yi Shao, Monique Gandawidjaja, Tara Tabibi, Noam Grysman & George T. Grossberg. (2022) Comparison of the Impact of the Mediterranean Diet, Anti-Inflammatory Diet, Seventh-Day Adventist Diet, and Ketogenic Diet Relative to Cognition and Cognitive Decline. Current Nutrition Reports 11:2, pages 161-171.
Crossref
Crossref
Jinglin Zhou, Ke Ning, Yi Yang, Ling Zou, Jing Xue, Xiangli Kong & Wei Li. (2022) 1H-NMR -based metabolic analysis on biocompatibility of dental biomaterials. Process Biochemistry 114, pages 163-173.
Crossref
Crossref
Jian-Hong Wang, Lei Guo, Su Wang, Neng-Wei Yu & Fu-Qiang Guo. (2022) The potential pharmacological mechanisms of β-hydroxybutyrate for improving cognitive functions. Current Opinion in Pharmacology 62, pages 15-22.
Crossref
Crossref
Guido Dorman, Ignacio Flores, Carlos Gutiérrez, Ramiro Fernández Castaño, Mayra Aldecoa & Leandro Kim. (2022) Medicinal Herbs and Nutritional Supplements for Dementia Therapy:
Potential Targets and Clinical Evidence. CNS & Neurological Disorders - Drug Targets 21:1, pages 26-51.
Crossref
Crossref
Ziying Jiang, Xi Yin, Miao Wang, Tong Chen, Yuanyuan Wang, Zhongbao Gao & Zhenfu Wang. (2022) Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases. Aging and disease 13:4, pages 1146.
Crossref
Crossref
Paul C. Guest. 2022. Physical Exercise and Natural and Synthetic Products in Health and Disease. Physical Exercise and Natural and Synthetic Products in Health and Disease
191
202
.
Gülsüm KARA & Gül Eda KILINÇ. (2021) Alzheimer Hastalığında Ketojenik Diyet TedavisiKetogenic Diet Treatment in Alzheimer’s Disease. İstanbul Gelişim Üniversitesi Sağlık Bilimleri Dergisi:15, pages 630-638.
Crossref
Crossref
P.G. Roopashree, Shilpa S. Shetty & N. Suchetha Kumari. (2021) Effect of medium chain fatty acid in human health and disease. Journal of Functional Foods 87, pages 104724.
Crossref
Crossref
E. V. Ivannikova, M. A. Altashina & E. A. Troshina. (2021) The ketogenic diet: history, mechanism of action, indications and contraindications. Problems of Endocrinology 68:1, pages 49-72.
Crossref
Crossref
Salva R. Yurista, Christopher T. Nguyen, Anthony Rosenzweig, Rudolf A. de Boer & B. Daan Westenbrink. (2021) Ketone bodies for the failing heart: fuels that can fix the engine?. Trends in Endocrinology & Metabolism 32:10, pages 814-826.
Crossref
Crossref
Kei-Lin Murata Ooi, Kristina Vacy & Wah Chin Boon. (2021) Fatty acids and beyond: Age and Alzheimer's disease related changes in lipids reveal the neuro-nutraceutical potential of lipids in cognition. Neurochemistry International 149, pages 105143.
Crossref
Crossref
Dariusz Włodarek. (2021) The possibility of use of the ketogenic diet and medium chain triglycerides supplementation in the support therapy of Alzheimer disease. Current Opinion in Clinical Nutrition & Metabolic Care 24:4, pages 385-391.
Crossref
Crossref
Yukihito Yomogida, Junko Matsuo, Ikki Ishida, Miho Ota, Kentaro Nakamura, Kinya Ashida & Hiroshi Kunugi. (2021) An fMRI Investigation into the Effects of Ketogenic Medium-Chain Triglycerides on Cognitive Function in Elderly Adults: A Pilot Study. Nutrients 13:7, pages 2134.
Crossref
Crossref
Oliver Chen, Traci Blonquist, Eunice Mah, Kristen Sanoshy, Dawn Beckman, Kristin Nieman, Barbara Winters, Joshua Anthony, Eric Verdin, John Newman & Brianna Stubbs. (2021) Tolerability and Safety of a Novel Ketogenic Ester, Bis-Hexanoyl (R)-1,3-Butanediol: A Randomized Controlled Trial in Healthy Adults. Nutrients 13:6, pages 2066.
Crossref
Crossref
Karyn Brackley. (2021) The cerebral hypometabolism model of Alzheimer's disease explored: can a ketogenic diet improve cognition in Alzheimer's disease? A review of the literature. British Journal of Neuroscience Nursing 17:3, pages 95-103.
Crossref
Crossref
Aleksandra Kaliszewska, Joseph Allison, Matteo Martini & Natalia Arias. (2021) The Interaction of Diet and Mitochondrial Dysfunction in Aging and Cognition. International Journal of Molecular Sciences 22:7, pages 3574.
Crossref
Crossref
Jordan Lam, Justin Lee, Charles Y. Liu, Andres M. Lozano & Darrin J. Lee. (2021) Deep Brain Stimulation for Alzheimer’s Disease: Tackling Circuit Dysfunction. Neuromodulation: Technology at the Neural Interface 24:2, pages 171-186.
Crossref
Crossref
Joshua J. Davis, Nicole Fournakis & James Ellison. (2020) Ketogenic Diet for the Treatment and Prevention of Dementia: A Review. Journal of Geriatric Psychiatry and Neurology 34:1, pages 3-10.
Crossref
Crossref
Matthieu Lilamand, Baptiste Porte, Emmanuel Cognat, Jacques Hugon, François Mouton-Liger & Claire Paquet. (2020) Are ketogenic diets promising for Alzheimer’s disease? A translational review. Alzheimer's Research & Therapy 12:1.
Crossref
Crossref
Md. Sahab Uddin, Md. Tanvir Kabir, Devesh Tewari, Abdullah Al Mamun, George E. Barreto, Simona G. Bungau, May N. Bin-Jumah, Mohamed M. Abdel-Daim & Ghulam Md Ashraf. (2020) Emerging Therapeutic Promise of Ketogenic Diet to Attenuate Neuropathological Alterations in Alzheimer’s Disease. Molecular Neurobiology 57:12, pages 4961-4977.
Crossref
Crossref
Tianying Zhang, Xiaojuan Han, Xiaohua Zhang, Zhi Chen, Yajing Mi & Xingchun Gou. (2020) Dietary Fatty Acid Factors in Alzheimer’s Disease: A Review. Journal of Alzheimer's Disease 78:3, pages 887-904.
Crossref
Crossref
Ahmed M. Shehata, Omar A. Ahmed-Farid, Hanan A. Rizk, Sara M. Saber, Fawzy M. Lashin & Lamberto Re. (2020) Neurochemical, neurobehavioral and histochemical effects of therapeutic dose of l-dopa on striatal neurons in rats: Protective effect of virgin coconut oil. Biomedicine & Pharmacotherapy 130, pages 110473.
Crossref
Crossref
Sakiko Abe, Osamu Ezaki & Motohisa Suzuki. (2020) Medium-Chain Triglycerides (8:0 and 10:0) Increase Mini-Mental State Examination (MMSE) Score in Frail Elderly Adults in a Randomized Controlled Trial. The Journal of Nutrition 150:9, pages 2383-2390.
Crossref
Crossref
Azrul Abdul Kadir, Kieran Clarke & Rhys D. Evans. (2020) Cardiac ketone body metabolism. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1866:6, pages 165739.
Crossref
Crossref
Rui‐Jun Li, Yang Liu, Huan‐Qiu Liu & Ji Li. (2020) Ketogenic diets and protective mechanisms in epilepsy, metabolic disorders, cancer, neuronal loss, and muscle and nerve degeneration. Journal of Food Biochemistry 44:3.
Crossref
Crossref
Konstantinos I. Avgerinos, Josephine M. Egan, Mark P. Mattson & Dimitrios Kapogiannis. (2020) Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer’s disease. A systematic review and meta-analysis of human studies. Ageing Research Reviews 58, pages 101001.
Crossref
Crossref
Lucy Camberos-Luna & Lourdes Massieu. (2020) Therapeutic strategies for ketosis induction and their potential efficacy for the treatment of acute brain injury and neurodegenerative diseases. Neurochemistry International 133, pages 104614.
Crossref
Crossref
TOHRU OHNUMA. (2020) Current Nutritional Approaches and Clinical Interventions for Alzheimer’s Disease. Juntendo Medical Journal 66:2, pages 162-171.
Crossref
Crossref
Paul C. Guest. 2020. Clinical and Preclinical Models for Maximizing Healthspan. Clinical and Preclinical Models for Maximizing Healthspan
3
28
.
Mustafa Gokce, Muhammed Yunus Bektay, Rabia Selvitop, Ali Toprak & Gulsen Babacan Yildiz. (2019) Investigation of the Effects of Biochemical Parameters on Alzheimer’s Disease. American Journal of Alzheimer's Disease & Other Dementias® 34:7-8, pages 464-468.
Crossref
Crossref
Marta Rusek, Ryszard Pluta, Marzena Ułamek-Kozioł & Stanisław J. Czuczwar. (2019) Ketogenic Diet in Alzheimer’s Disease. International Journal of Molecular Sciences 20:16, pages 3892.
Crossref
Crossref
Barry V. O'Neill, Chris M. Dodds, Sam R. Miller, Ashutosh Gupta, Philip Lawrence, Jonathan Bullman, Chao Chen, Odile Dewit, Subramanya Kumar, Mushi Dustagheer, Jeffrey Price, Shaila Shabbir & Pradeep J. Nathan. (2019) The effects of GSK2981710, a medium‐chain triglyceride, on cognitive function in healthy older participants: A randomised, placebo‐controlled study. Human Psychopharmacology: Clinical and Experimental 34:3, pages e2694.
Crossref
Crossref
Klaus W. Lange, Jianjun Guo, Shigehiko Kanaya, Katharina M. Lange, Yukiko Nakamura & Shiming Li. (2019) Medical foods in Alzheimer’s disease. Food Science and Human Wellness 8:1, pages 1-7.
Crossref
Crossref
Miho Ota, Junko Matsuo, Ikki Ishida, Harumasa Takano, Yuma Yokoi, Hiroaki Hori, Sumiko Yoshida, Kinya Ashida, Kentaro Nakamura, Takeshi Takahashi & Hiroshi Kunugi. (2019) Effects of a medium-chain triglyceride-based ketogenic formula on cognitive function in patients with mild-to-moderate Alzheimer’s disease. Neuroscience Letters 690, pages 232-236.
Crossref
Crossref
Francesca L. Guest. 2019. Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders. Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders
295
317
.
Tanya J. W. McDonald & Mackenzie C. Cervenka. (2018) Ketogenic Diets for Adult Neurological Disorders. Neurotherapeutics 15:4, pages 1018-1031.
Crossref
Crossref
Tanya McDonald & Mackenzie Cervenka. (2018) The Expanding Role of Ketogenic Diets in Adult Neurological Disorders. Brain Sciences 8:8, pages 148.
Crossref
Crossref
Alessandro Pinto, Alessio Bonucci, Elisa Maggi, Mariangela Corsi & Rita Businaro. (2018) Anti-Oxidant and Anti-Inflammatory Activity of Ketogenic Diet: New Perspectives for Neuroprotection in Alzheimer’s Disease. Antioxidants 7:5, pages 63.
Crossref
Crossref
Charlotte Veyrat-Durebex, Pascal Reynier, Vincent Procaccio, Rudolf Hergesheimer, Philippe Corcia, Christian R. Andres & Hélène Blasco. (2018) How Can a Ketogenic Diet Improve Motor Function?. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
Katrin Augustin, Aziza Khabbush, Sophie Williams, Simon Eaton, Michael Orford, J Helen Cross, Simon J R Heales, Matthew C Walker & Robin S B Williams. (2018) Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders. The Lancet Neurology 17:1, pages 84-93.
Crossref
Crossref
Ayako Kimoto, Tohru Ohnuma, Aiko Toda, Yuto Takebayashi, Ryoko Higashiyama, Yuko Tagata, Masanobu Ito, Tsuneyoshi Ota, Nobuto Shibata & Heii Arai. (2017) Medium-chain triglycerides given in the early stage of mild-to-moderate Alzheimer's disease enhance memory function. Psychogeriatrics 17:6, pages 520-521.
Crossref
Crossref
Sakiko ABE, Osamu EZAKI & Motohisa SUZUKI. (2017) Medium-Chain Triglycerides in Combination with Leucine and Vitamin D Benefit Cognition in Frail Elderly Adults: A Randomized Controlled Trial. Journal of Nutritional Science and Vitaminology Journal of Nutritional Science and Vitaminology 63:2, pages 133-140.
Crossref
Crossref
Francesco Bonetti, Gloria Brombo & Giovanni Zuliani. 2017. Nutrition and Functional Foods for Healthy Aging. Nutrition and Functional Foods for Healthy Aging
211
232
.
Mehmet Akif Topcuoglu & Ethem Murat Arsava. 2017. Nutrition in Neurologic Disorders. Nutrition in Neurologic Disorders
155
206
.
Michael Nehls. (2016) Unified theory of Alzheimer’s disease (UTAD): implications for prevention and curative therapy. Journal of Molecular Psychiatry 4:1.
Crossref
Crossref